Results 161 to 170 of about 1,715,615 (239)

Monoallelic BRCA1/2 variants in pediatric, adolescent, and young adult patients with central nervous system tumors. [PDF]

ESMO Open
Cipri S, Agolini E, Baldo GD, Cacchione A, Megaro G, Rossi S, Barresi S, Carai A, Colafati GS, Boccuto L, Mastronuzzi A.   +10 more
europepmc   +1 more source

A Germline <i>BRCA2</i> Pathogenic Variant Identified by Multigene Panel Testing in Upper Tract Urothelial Carcinoma. [PDF]

IJU Case Rep
Matsuo K, Zennami K, Yoshida M, Hatakeyama M, Morikawa M, Hattori K, Akamatsu S.   +6 more
europepmc   +1 more source

Shaping CDK4/6 Inhibitor Resistance: BRCA2 Germline Alterations Bias toward RB1 Inactivation. [PDF]

Cancer Res
Napolitano F, Hanker AB.
europepmc   +1 more source

Prognostic and therapeutic implications of BRCA1 and BRCA2 mutations in ovarian cancer. [PDF]

Front Oncol
Pawul W, Opoka P, Dusza A, Blajerski B, Orzelska J, Gierulska N, Kułak K, Tarkowski R.   +7 more
europepmc   +1 more source

Preimplantation genetic testing for concurrent Meckel Syndrome and hereditary breast cancer in a Chinese family harboring a novel NPHP3 pathogenic variant and a canonical BRCA2 frameshift variant. [PDF]

Genet Mol Biol
Zhang Y, Huang X, Qiu P, Ji H, Ding L, He X, Shi Y, Huang Y, Li P, Mei L.   +9 more
europepmc   +1 more source

Somatic Mutation Profile in Normal Tissue Adjacent to Tumor in Colorectal Carcinoma Patients: Functional Effect on Gene Expression and Potential Implications for Precision Medicine. [PDF]

Cancers (Basel)
Jasmine F, Vasiljevs D, Almazan A, Ahsan H, Kibriya MG.   +4 more
europepmc   +1 more source

Recent Advances in Genetic Testing and Clinical Management of Hereditary Breast and Ovarian Cancer (HBOC) in India. [PDF]

Cancer Med
Sherigar P, Kedlaya Herga S, Pai A, Mailankody S, Udupa KS.   +4 more
europepmc   +1 more source

Report of Multilocus Inherited Neoplasia Alleles Syndrome in a Chilean Oncology Institute: New Combinations and Genetic Landscape. [PDF]

Genes (Basel)
Sepúlveda Bustos F, Martin Merlez F, Campos Jadrijevic D, Saavedra MP, Selman Bravo C.   +4 more
europepmc   +1 more source

Clinical Impact of Germline Pathogenic Variants in High-risk Prostate Cancer Treated with Radiotherapy. [PDF]

Eur Urol Open Sci
Galego-Carro J, Santamariña M, Blanco-Pérez A, Aguado-Barrera ME, Amigo J, Fuentes-Ríos O, Coedo-Costa C, Calvo-Crespo P, Peleteiro-Higuero P, Carballo-Castro AM, Taboada-Valladares B, Gómez-Caamaño A, Vega A.   +12 more
europepmc   +1 more source

Impact of BRCA2 pathogenic variants on outcomes to first-line CDK4/6 inhibitors plus endocrine therapy in HR-positive/HER2-negative metastatic breast cancer. [PDF]

ESMO Open
Cruellas M, Rodriguez-Hernandez A, Carità L, Seguí E, Cejuela M, Lema L, García-Torralba E, Roqué-Lloveras A, Fernández-Ortega A, Melé M, Tapia M, Servitja S, González-Santiago S, Blaya-Boluda N, Bellet M, Martínez-Sáez O, Pimentel I, García-Fructuoso I, Pascual T, Joval-Ramentol L, Viñas G, Rey Aceituno M, Casas A, Castillo E, Brasó-Maristany F, Vivancos A, Serra V, Villacampa G, Oliveira M, Prat A, Saura C, Adamo B, Balmaña J.   +32 more
europepmc   +1 more source